UK markets closed

BiomX Inc. (PHGE)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.3500-0.0150 (-4.11%)
As of 11:26AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
30/06/2019
Cash flows from operating activities
Net income
-26,169
-26,169
-28,317
-36,226
-30,086
-
-
Depreciation & amortisation
871
871
2,520
2,565
2,180
-
-
Deferred income taxes
-
-
-
-
-
-
-1.222
Stock-based compensation
1,059
1,059
1,529
3,237
2,890
-
-
Change in working capital
2,476
2,476
-4,428
3,103
453
-
-
Accounts payable
556
556
-1,975
427
-858
-
-
Other working capital
-21,336
-21,336
-29,204
-31,255
-25,456
-
-
Other non-cash items
477
477
-396
-252
116
-
-
Net cash provided by operating activities
-21,286
-21,286
-29,092
-27,573
-24,447
-
-
Cash flows from investing activities
Investments in property, plant and equipment
-50
-50
-112
-3,682
-1,009
-
-
Purchases of investments
0
0
-13,500
0
-49,780
-
-
Sales/maturities of investments
2,000
2,000
11,500
19,851
39,932
-
-
Other investing activities
-
-
-
-
-9,848
21,052
-
Net cash used for investing activities
1,951
1,951
-2,107
16,173
-10,857
-
-
Cash flows from financing activities
Debt repayment
-4,253
-4,253
0
-
-
-
-105.5
Common stock issued
7,485
7,485
273
22,925
-
1,800
-
Common stock repurchased
-
-
-
-
-98
-19
-
Other financing activities
-333
-333
19
-
-75
59,673
-
Net cash used provided by (used for) financing activities
2,899
2,899
292
37,280
134
-
-
Net change in cash
-16,436
-16,436
-30,907
25,880
-35,170
-
-
Cash at beginning of period
32,294
32,294
63,095
37,240
72,410
-
-
Cash at end of period
15,864
15,864
32,294
63,095
37,240
-
-
Free cash flow
Operating cash flow
-21,286
-21,286
-29,092
-27,573
-24,447
-
-
Capital expenditure
-50
-50
-112
-3,682
-1,009
-
-
Free cash flow
-21,336
-21,336
-29,204
-31,255
-25,456
-
-